EMBC logo

EMBC
Embecta Corp

179
Mkt Cap
$515.8M
Volume
961.00
52W High
$15.55
52W Low
$8.47
PE Ratio
3.67
EMBC Fundamentals
Price
$8.71
Prev Close
$9.03
Open
$9.03
50D MA
$9.32
Beta
1.04
Avg. Volume
931,639.07
EPS (Annual)
$1.62
P/B
-0.84
Rev/Employee
$584,000.00
$2,050.09
Loading...
Loading...
News
all
press releases
Embecta (EMBC) to Release Quarterly Earnings on Tuesday
Embecta (NASDAQ:EMBC) will be releasing its Q2 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-embecta-corp-stock...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Embecta Corp. $EMBC Shares Sold by State of Alaska Department of Revenue
State of Alaska Department of Revenue cut its position in Embecta Corp. (NASDAQ:EMBC - Free Report) by 88.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,300 shares of the company's stock after...
MarketBeat·4d ago
News Placeholder
Massachusetts Financial Services Co. MA Purchases 187,301 Shares of Embecta Corp. $EMBC
Massachusetts Financial Services Co. MA raised its position in shares of Embecta Corp. (NASDAQ:EMBC - Free Report) by 1,212.9% in the fourth quarter, according to the company in its most recent...
MarketBeat·12d ago
News Placeholder
SG Americas Securities LLC Acquires Shares of 435,842 Embecta Corp. $EMBC
SG Americas Securities LLC bought a new position in Embecta Corp. (NASDAQ:EMBC - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 435,842 shares of the company's stock, valued at approximately $5,1...
MarketBeat·28d ago
News Placeholder
JPMorgan Chase & Co. Boosts Stock Position in Embecta Corp. $EMBC
JPMorgan Chase & Co. lifted its holdings in shares of Embecta Corp. (NASDAQ:EMBC - Free Report) by 39.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·29d ago
News Placeholder
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest
Embecta Corp. (NASDAQ:EMBC - Get Free Report) saw a significant growth in short interest in March. As of March 13th, there was short interest totaling 5,617,135 shares, a growth of 19.4% from the...
MarketBeat·30d ago
News Placeholder
Embecta (NASDAQ:EMBC) Sets New 12-Month Low - Time to Sell?
Embecta (NASDAQ:EMBC) Hits New 1-Year Low - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
Zacks·1mo ago
News Placeholder
Embecta (NASDAQ:EMBC) Trading 4.5% Higher - Time to Buy?
Embecta (NASDAQ:EMBC) Shares Up 4.5% - Should You Buy...
MarketBeat·1mo ago
News Placeholder
Embecta Rallies After UK Firm Deal Worth $200 Million
Embecta announces $200 million Owen Mumford deal aimed at boosting growth and expanding drug delivery in diabetes and obesity care markets.read more...
Benzinga·1mo ago
<
1
2
...
>

Latest EMBC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.